+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Legal Marijuana Market Size, Share & Trends Analysis Report by Product Type (Flower, Oil), by Marijuana Type (Adult, Medical), by Medical Use (Chronic Pain, Mental Disorders, Cancer), by Region, and Segment Forecasts, 2020 - 2027

  • ID: 5144628
  • Report
  • August 2020
  • Region: North America
  • 150 pages
  • Grand View Research

FEATURED COMPANIES

  • Aphria, Inc.
  • Aurora Cannabis
  • CannTrust Holdings
  • Canopy Growth Corporation
  • Lexaria Bioscience Corp.
  • Organigram Holdings, Inc.
North America Legal Marijuana Market Growth & Trends

The North America legal marijuana market size is expected to reach USD 104.9 billion by 2027, expanding at a CAGR of 15.5% over the forecast period. Growing consumer awareness regarding various health benefits offered by medical cannabis and increasing legalization is contributing to the adoption of these products in the region. Moreover, consumer shift towards plant-based treatments such as marijuana for pain management is likely to fuel the growth of the market. Furthermore, changing buyer perception and attitude toward these products is further bolstering revenue growth during the forecast period.

Based on the product type, the flower segment dominated the market in 2019. This growth is attributed to various factors such as increasing legalization, rise in the consumption of these products, increasing usage of marijuana flowers for smoking, and growing awareness regarding benefits offered by marijuana. In addition, companies are constantly trying to diversify their products into different forms to cater to a larger consumer pool to improve product penetration into newer consumer segments and increase brand visibility. However, the adverse effects of the smoking flower are anticipated to hinder segment growth over the forecast period. On the other hand, the oil products segment is anticipated to witness the fastest growth over the forecast period owing to potential health benefits offered by these products as well as increasing efficiency in managing health conditions.

Based on the marijuana type, the adult-type segment dominated the market in 2019 owing to the legalization of marijuana for adult use. Moreover, health benefits offered by medical cannabis for various conditions such as sleep disorders, analgesia, and mental disorders have fueled market growth in the region. On the other hand, the medical type segment is anticipated to be the fastest-growing segment during the forecast period owing to the presence of a large patient pool in the region.

Based on medical use, the chronic pain segment accounted for the largest revenue share in the legal marijuana market in 2019. Growing susceptibility towards chronic pain among the geriatric population coupled with increasing legalization of marijuana is contributing towards the segment growth in the region. Moreover, consumer shift from opioid treatment towards plant-based treatments such as marijuana for pain management is further boosting its adoption. On the other hand, the mental disorders segment is anticipated to be the fastest-growing segment during the forecast period owing to the increasing acceptance, and a rise in product demand for treating mental disorders.

In 2019, Canada dominated the market owing to the recent legalization of recreational marijuana, a large population base, and the presence of key marijuana cultivators and manufacturers in the country. On the other hand, the U.S. is anticipated to be the fastest-growing country during the forecast period owing to the rise in product adoption and increasing government approvals. Moreover, increasing support by U.S. citizens regarding the usage of medical cannabis in the country will fuel the market growth during the forecast period.

North America Legal Marijuana Market Report Highlights
  • The flower product type segment dominated the market in 2019, owing to affirmative legal scenarios, easy availability, and lower costs.
  • The adult marijuana type segment dominated the market in 2019 owing to increasing legalization of medical cannabis for adult use.
  • The chronic pain medical use segment dominated the market in 2019 owing to the rising geriatric population and increasing prevalence of chronic pain in the region.
  • Canada dominated the market in 2019 owing to a large population base and the presence of a large number of manufacturers in the country.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aphria, Inc.
  • Aurora Cannabis
  • CannTrust Holdings
  • Canopy Growth Corporation
  • Lexaria Bioscience Corp.
  • Organigram Holdings, Inc.
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.3.1 Country Market: CAGR Calculation
1.4 Country Based Segment Share Calculation
1.5 List of Secondary Data Sources
1.6 List of Primary Sources

Chapter 2 Executive Summary
2.1 Market Summary

Chapter 3 North America Legal Marijuana Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Penetration & Growth Prospects Mapping
3.3 North America Legal Marijuana Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing Adoption Of Legal Marijuana For Treatment Of Chronic Diseases
3.3.1.2 Growing Legalization Of Marijuana
3.3.1.3 Increasing Revenues Owing To Levied Taxes
3.3.1.4 Increasing Preference Towards Marijuana Extracts
3.3.2 Market Restraints Analysis
3.3.2.1 High Pricing Of Marijuana Compared To Illegal Markets
3.3.2.2 Strict Government Regulations
3.3.3 Industry Challenges
3.3.3.1 Incomplete Evidence Regarding The Effectiveness Of Legal Marijuana
3.3.3.2 Reluctance Of Doctors To Prescribe Marijuana
3.3.3.3 Lower Market Access To Marijuana Leading To Smuggling
3.4 North America Legal Marijuana Market Analysis Tools
3.4.1 North America Legal Marijuana Market-Pestle Analysis
3.4.1.1 Political & Legal
3.4.1.2 Economic
3.4.1.3 Technological
3.4.2 Industry Analysis-Porter’s
3.5 Opportunity Analysis (2016-2019-2027)
3.6 North America Legal Marijuana Market Regulatory Scenario, by State/Province
3.6.1 The U.S.
3.6.1.1 Washington
3.6.1.2 Oregon
3.6.1.3 California
3.6.1.4 Nevada
3.6.1.5 Distrcit Of Colombia
3.6.1.6 Georgia
3.6.1.7 Alaska
3.6.1.8 Colorado
3.6.1.9 Michigan
3.6.1.10 Maine
3.6.1.11 Vermont
3.6.1.12 Massachusetts
3.6.1.13 Montana
3.6.1.14 Utah
3.6.1.15 Arizona
3.6.1.16 New Mexico
3.6.1.17 North Dakota
3.6.1.18 Oklahoma
3.6.1.19 Missouri
3.6.1.20 Arkansas
3.6.1.21 Louisiana
3.6.1.22 Illinois
3.6.1.23 Minnesota
3.6.1.24 Ohio
3.6.1.25 West Virginia
3.6.1.26 Pennsylvania
3.6.1.27 Maryland
3.6.1.28 Delaware
3.6.1.29 New Jersey
3.6.1.30 New York
3.6.1.31 Connecticut
3.6.1.32 Rhode Island
3.6.1.33 New Hampshire
3.6.1.34 Florida
3.6.2 Canada
3.6.2.1 Alberta
3.6.2.2 British Columbia
3.6.2.3 Prince Edward Island (Pei)
3.6.2.4 Manitoba
3.6.2.5 New Brunswick
3.6.2.6 Nova Scotia
3.6.2.7 Ontario
3.6.2.8 Quebec
3.6.2.9 Saskatchewan
3.6.2.10 Newfoundland and Labrador
3.6.2.11 Nunavut
3.6.2.12 Yukon
3.6.2.13 Northwest Territories
3.7 Marijuana User Pool Analysis, By Country

Chapter 4 North America Legal Marijuana Market: Product Type Estimates & Trend Analysis
4.1 North America Legal Marijuana Market: Product Type Movement Analysis
4.2 Flower
4.2.1 Flower Market Estimates and Forecasts, 2016-2027 (USD Million)
4.3 Oil
4.3.1 Oil Market Estimates and Forecasts, 2016-2027 (USD Million)

Chapter 5 North America Legal Marijuana Market: Application Estimates & Trend Analysis
5.1 North America Legal Marijuana Market: Application Movement Analysis
5.2 Medical Use
5.2.1 Medical Use Market Estimates and Forecasts, 2016-2027 (USD Million)
5.2.2 Chronic Pain
5.2.2.1 Chronic Pain Market Estimates and Forecasts, 2016-2027 (USD Million)
5.2.3 Mental Disorders
5.2.3.1 Mental Disorders Market Estimates and Forecasts, 2016-2027 (USD Million)
5.2.4 Cancer
5.2.4.1 Cancer Market Estimates and Forecasts, 2016-2027 (USD Million)
5.2.5 Others
5.2.5.1 Other Applications Market Estimates and Forecasts, 2016-2027 (USD Million)
5.3 Adult Use
5.3.1 Adult Use Market Estimates and Forecasts, 2016-2027 (USD Million)

Chapter 6 North America Legal Marijuana Market: Regional Estimates & Trend Analysis, by Product Type and Application
6.1 North America Legal Marijuana Market: Country Movement Analysis
6.1.1 The U.S.
6.1.1.1 The U.S. Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.2 Washington
6.1.1.2.1 Washington Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.3 Oregon
6.1.1.3.1 Oregon Legal Marijuna Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.4 California
6.1.1.4.1 California Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.5 Nevada
6.1.1.5.1 Nevada Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.6 District Of Columbia
6.1.1.6.1 District Of Columbia Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.7 Georgia
6.1.1.7.1 Georgia Legal Marijuna Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.8 Alaska
6.1.1.8.1 Alaska Legal Marijuna Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.9 Colorado
6.1.1.9.1 Colorado Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.10 Michigan
6.1.1.10.1 Michigan Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.11 Maine
6.1.1.11.1 Maine Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.12 Vermont
6.1.1.12.1 Vermont Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.13 Massachusetts
6.1.1.13.1 Massachusetts Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.14 Montana
6.1.1.14.1 Montana Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.15 Utah
6.1.1.15.1 Utah Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.16 Arizona
6.1.1.16.1 Arizona Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.17 New Mexico
6.1.1.17.1 New Mexico Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.18 North Dakota
6.1.1.18.1 North Dakota Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.19 Oklahoma
6.1.1.19.1 Oklahoma Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.20 Missouri
6.1.1.20.1 Missouri Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.21 Arkansas
6.1.1.21.1 Arkansas Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.22 Louisiana
6.1.1.22.1 Louisiana Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.23 Illinois
6.1.1.23.1 Illinois Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.24 Minnesota
6.1.1.24.1 Minnesota Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.25 Ohio
6.1.1.25.1 Ohio Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.26 West Virginia
6.1.1.26.1 West Virginia Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.27 Pennsylvania
6.1.1.27.1 Pennsylvania Legal Marijuna Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.28 Maryland
6.1.1.28.1 Maryland Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.29 Delaware
6.1.1.29.1 Delaware Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.30 New Jersey
6.1.1.30.1 New Jersey Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.31 New York
6.1.1.31.1 New York Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.32 Connecticut
6.1.1.32.1 Connecticut Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.33 Rhode Island
6.1.1.33.1 Rhode Island Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.34 New Hampshire
6.1.1.34.1 New Hampshire Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.1.35 Florida
6.1.1.35.1 Florida Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2 Canada
6.1.2.1 Canada Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.2 Alberta
6.1.2.2.1 Alberta Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.3 British Columbia
6.1.2.3.1 British Columbia Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.4 Prince Edward Island (Pei)
6.1.2.4.1 Pei Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.5 Manitoba
6.1.2.5.1 Manitoba Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.6 New Brunswick
6.1.2.6.1 New Brunswick Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.7 Nova Scotia
6.1.2.7.1 Nova Scotia Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.8 Ontario
6.1.2.8.1 Ontario Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.9 Quebec
6.1.2.9.1 Quebec Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.10 Saskatchewan
6.1.2.10.1 Saskatchewan Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.11 Newfoundland and Labrador (N.L.)
6.1.2.11.1 N.L. Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.12 Nunavut
6.1.2.12.1 Nunavut Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.13 Yukon
6.1.2.13.1 Yukon Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)
6.1.2.14 Northwest Territories
6.1.2.14.1 Northwest Territories Legal Marijuana Market Estimates and Forecasts, 2016-2027 (USD Million)

Chapter 7 Competitive Landscape
7.1 Company Profiles
7.1.1 Canopy Growth Corporation
7.1.1.1 Company Overview
7.1.1.2 Financial Performance
7.1.1.3 Strategic Initiatives
7.1.2 Aphria, Inc.
7.1.2.1 Company Overview
7.1.2.2 Financial Performance
7.1.2.3 Strategic Initiatives
7.1.3 Aurora Cannabis
7.1.3.1 Company Overview
7.1.3.2 Financial Performance
7.1.3.3 Strategic Initiatives
7.1.4 Tilray
7.1.4.1 Company Overview
7.1.4.2 Financial Performance
7.1.4.3 Strategic Initiatives
7.1.5 Organigram Holdings, Inc.
7.1.5.1 Company Overview
7.1.5.2 Financial Performance
7.1.5.3 Strategic Initiatives
7.1.6 Lexaria Bioscience Corp.
7.1.6.1 Company Overview
7.1.6.2 Financial Performance
7.1.6.3 Strategic Initiatives
7.1.7 ABcann Medicinals, Inc. (Part of Vivo Cannabis)
7.1.7.1 Company Overview
7.1.7.2 Financial Performance
7.1.7.3 Strategic Initiatives
7.1.8 The Cronos Group
7.1.8.1 Company Overview
7.1.8.2 Financial Performance
7.1.8.3 Strategic Initiatives
7.1.9 Wayland Group Corp. (Maricann Group Inc.)
7.1.9.1 Company Overview
7.1.9.2 Financial Performance
7.1.9.3 Strategic Initiatives
7.1.10 CannTrust Holdings
7.1.10.1 Company Overview
7.1.10.2 Financial Performance
7.1.10.3 Strategic Initiatives
Note: Product cover images may vary from those shown
  • Canopy Growth Corporation
  • Aphria, Inc.
  • Aurora Cannabis
  • Tilray
  • Organigram Holdings, Inc.
  • Lexaria Bioscience Corp.
  • ABcann Medicinals, Inc. (Part of Vivo Cannabis)
  • The Cronos Group
  • Wayland Group Corp. (Maricann Group Inc.)
  • CannTrust Holdings
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll